Altered basic fibroblast growth factor expression in common epidermal neoplasms: Examination with in situ hybridization and unohistochemist

Journal of the American Academy of Dermatology

Volumn 42, Issue 6, 2000, Pages 973-977

  Arbiser, Jack L ^a   Byers, H Randolph ^b   Cohen, Cynthia ^a   Arbeit, Jeffrey ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ARTICLE; CONTROLLED STUDY; EPIDERMIS; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; PRIORITY JOURNAL; RNA TRANSLATION; SKIN TUMOR;

EID: 0034129547     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.104792     Document Type: Article

References (31)

1. Arbiser JL. Angiogenesis and the skin: a primer. J Am Acad Dermatol 1996;34:486-97.
2. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor derived capillary endothelial growth factor. Science 1984;223:1296-9.
3. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey JS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
4. Burgess WH, Maciag T. The heparin binding fibroblast growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
5. Burke D, Wilkes D, Blundell TL, Malcolm S. Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 1998;23:59-62.
6. Naski MC, Wang Q, Xu J, Ornitz DM. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 1996;2:233-7.
7. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996;84:911-21.
8. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995;4:462-4.
9. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 1998;95:5672-7.
10. Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ, Wellstein A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med 1997;3:1137-40.
11. Arbiser JL, Fine JD, Murrell D, Paller A, Connors S, Keough K, et al. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Mol Med 1998;4:191-5.
12. O'Keefe EJ, Chiu ML, Payne RE Jr. Stimulation of growth of keratinocytes by basic fibroblast growth factor. J Invest Dermatol 1988;90:767-9.
13. Tsuboi R, Sato Y, Rifkin DB. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 1990;110:511-7.
14. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
15. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci U S A 1995;92:4562-6.
16. Becker D, Meier CB, Herlyn M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 1989;8: 3685-91.
17. Halaban R. Growth factors and melanomas. Semin Oncol 1996;23:673-81.
18. Arbeit JM, Olson DC, Hanahan D. Upregulation of fibroblast growth factors and their receptors during multistage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene 1996;13:1847-57.
19. Fu X, Shen Z, Chen Y, Xie J, Guo Z, Zhang M, et al. Randomized placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet 1998;352:1661-4.
20. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991;66:1095-1104.
21. Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 1998;111:864-72.
22. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 1988;331:173-5.
23. Cook PW, Coffey RJ Jr, Magun BE, Pittelkow MR, Shipley GD. Expression and regulation of mRNA coding for acidic and basic fibroblast growth factor and transforming growth factor alpha in cells derived from human skin. Mol Endocrinol 1990;4:1377-85.
24. LaFleur M, Underwood JL, Rappolee DA, Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 1996;184: 2311-26.
25. Ansel JC, Armstrong CA, Song I, Qinlan KL, Olerud JE, Caughman SW, et al. Interactions of the skin and nervous system. J Invest Dermatol Symp Proc 1997;2:23-6.
26. Curatola AM, Basilico C. Expression of the kFGF oncogene is controlled by 3′ regulatory elements which are specific for embryonal carcinoma cells. Mol Cell Biol 1990;10:2475-84.
27. Basilico C, Ambrosetti D, Fraidenraich D, Dailey L. Regulatory mechanisms governing expression during mouse development. J Cell Physiol 1997;173:227-32.
28. Niswander L, Martin GR. FGF-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 1992;114:755-68.
29. Yaguchi H, Tsuboi R, Ueki R, Ogawa H. Immunohistochemical localization of basic fibroblast growth factor in skin diseases. Acta Derm Venereol (Stockh) 1993;73:81-3.
30. Baly B, Maret A, Prats AC, Prats H. Cell transformation results in the loss of density-dependent translational regulation of the expression of fibroblast growth factor 2 isoforms. Cancer Res 1999;59:165-71.
31. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Flynn E, Byers HR. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998;4:376-83.